Paladin Labs Inc. Canada

Paladin Labs is a specialty pharmacetuical company that in-licenses and commercializes innovative drugs for the Canadian market.

Partnering objectives: In-licensing or acquiring innovative pharmaceutical products

Therapeutic Areas: All

Ms Anam Raja
Manager, Business Development 

Partners in Pharma LLC United States

Partners in Pharma LLC is a private partnership that offers independent strategic advice and business development support to the global pharmaceutical industry. The company is based in New Jersey, USA, but works with clients across the globe to help them grow their business.


We develop long-term relationships with our clients based on mutual trust and respect.  This enables us to better understand our clients and their needs and to provide them with more creative and comprehensive ideas.

Dr Michael Yeomans
President, Partners in Pharma LLC 
Mrs Elaine Yeomans
Managing Partner, Partners in Pharma LLC 

Perrigo Belgium

Perrigo is leading global healthcare company, a provider of branded OTC products throughout US and Europe. Perrigo is looking for IN-LICENSING of OTC products for all major OTC categories, such as cough, cold, allergy, smoking cessations, pain, sleep, mood, intimate hygiene, cholesterol, vitamins, natural OTC products etc.

Website:
www.perrigo.com
Silvie Medkova
Silvie Medkova
Senior Manager Business Development 

Petrone Group Italy

PETRONE GROUP is a privately-owned family company operating in the pharmaceutical, parapharmaceutical and health sector since 1965, with the main offices in Italy and branches in Spain, Singapore and Ireland.

The Group provides a wide range of warehousing, world-wide distribution services.

 Pharmaidea is a partner of excellence for pharmaceutical companies that want to increase their value in pharmacy retail market in Italy and Spain, through tailor-made  business models  through a multi-channel approach directed to different targets measurable by PharmaCo through shared KPIs.

Thanks to the Euromed division, our company ensures an efficient and timely distribution of authorized orphan drugs and unlicensed products on “order to cash” basis all over Europe in order to facilitate patients’ access to innovative drug treatments as early as possible.

We offer customized and full-integrated logistic services also for the management of “restricted and controlled” drugs and cold chain products. These services include the manufacture of primary and secondary packaging, warehouse storage, labelling and shipping, and product recall along with authorized destruction procedures (STM division).

Our company is also specialized in Global Comparator Sourcing and IMP Management for international clinical trials: Euromed Clinical Supply Services (Eclisse division) is GCP-compliant and provides IMP Production services in accordance with EU-GMP/CGMP legal requirements.

Our Group is listed in SPAIN (BCN Farma division) as Authorized to manage Medicamentos Especiales while in IRELAND we currently hold the GMP certification to Store unauthorized European and non- European drugs.

 

Website:
www.petrone.it
Mrs Claudia Rinaldi
Corporate Business Development 

pharma& Austria

A Pan-European Specialty Care Provider located in the hart of Europe aiming at satisfying patients, payers, divesting pharma and investors' needs alike  

Website:
Coming soon
Mr Frank Rotmann
Founder & Managing Director 

Pharmacloud Ltd United Kingdom

Ms Frances Cloud
Managing Director 

pharmBD France

For small and mid-size pharmaceutical companies, pharmBD is a "boutique-style" life sciences business development firm that offers customized expertise and services at all level of the deal making process. 

Website:
www.pharmbd.com
Ms Helene Moore
Ms Helene Moore
CEO 

PIERRE FABRE MEDICAMENT France

Mrs Claire KANONY-TRUC
Corporate Business Dev. & Licensing Project Manager 
Mrs Maria Teresa GALLARDO DOLS
CORPORATE BD & LICENSING MANAGER 

PMC Pharma Management Consultants GmbH Switzerland

Mergers & Acquisitions

We are a deal broker and M&A advisory boutique that is specializing in transactions in the corporate sector of the pharmaceutical and healthcare industry and the consumer goods industry.

We support our clients in

  • Purchase and sale of companies and participations
  • Purchase and sale of brands and product portfolios
  • Business cooperations

We carry out targeted searches for transaction opportunities worldwide and support our clients in all phases of the M&A process.

Due to our long experience in this field and our continuously updated network of more than 40,000 strategic and financial investors worldwide we are able to quickly identify suitable investors and/or targets and complete transactions discreetly and reliably.

Dr Marc Raber
Dr Marc Raber
Managing Director 
Mr Sascha Raber
Mr Sascha Raber
M&A Advisor 

Present Value United Kingdom

Present Value specialise in acquisition, divestment, licensing, partnering and strategy in life science. Our experience is purely pharmaceutical and anyone who works on your prospective project will have worked in the industry for some time.  Of course, we also benefit hugely from an excellent network that has been built organically through our project work (a recent project may saw us liaising with more than one hundred companies across Europe as an example).

Recently celebrating over 10 years of success for our clients, Present Value was founded back in 2007. You can get a flavour of the types of projects and transactions we work on by looking at some of the cases histories on our website.  Alternatively, please see below for a synopsis...

1. Acquire - We will find you new targets:

·         It is difficult to find businesses or assets to acquire, especially the right shape and size for your business. We have a structured way of hunting for deals and maintain a database of potential sellers. We can be your extra set of eyes and ears out there.

2. Divest - You deserve the right value for your asset or company:

·         We would not call a company Present Value if we did not understand the equation. It is not just about an equation, it is about a thorough understanding of what drives the value in your business. We have developed an efficient process to gain you best value for your asset. You get on with running your business while we organise all the relevant documentation and deal with potential buyers.

3. Licensing - Take the essential route to pharmaceutical licensing:

·         We spend a lot of time at the pharmaceutical industry’s partnering meetings and have a good idea of what each company is looking for or what they might be offering. We tend to stick to branded innovative licensing.

4. Consulting - Expert analysis on every aspect in business of Life Science:

·         If you are struggling with something or looking to get some fresh ideas, we work on all sorts of business development projects and strategies. They are always about unlocking extra value and getting the best out of your assets.

All our projects are bespoke to you and should your project require more specialist corporate finance, regulatory or legal input we can cover that too and tend to put together a bespoke team of competent individuals or complimentary firms.

Our past and current clients range from individual entrepreneurs, family firms, country subsidiaries and global entities.  We are proud of our track record of repeat and continuing business from a number of our clients, many of whom have taken us with them when they move to a new company.

If you would like to have a chat about how we can help, please call on +44 (0) 1892 825663 or if you at any PLG, EMIG, Bio Europe event, we’re likely to be there too.

We’re generally useful to know and we look forward to hearing from you.

Both Andrew Dean and Adam Minshall are available for meetings in Montreux.  Alternatively, why not just find either of us for an informal chat.

Mr Andrew Dean
Director 
Mr Adam Minshall
Mr Adam Minshall
Associate Director